Home/Filings/4/0001093557-18-000033
4//SEC Filing

GREGG TERRANCE H 4

Accession 0001093557-18-000033

CIK 0001093557other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 9:31 PM ET

Size

6.6 KB

Accession

0001093557-18-000033

Insider Transaction Report

Form 4
Period: 2018-03-08
GREGG TERRANCE H
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2018-03-08$0.00/sh+47,087$47531,646 total
Holdings
  • Common Stock

    (indirect: By IRA)
    11,461
  • Common Stock

    (indirect: By Trust)
    20,882
Footnotes (3)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
  • [F2]Included in this number are 47,087 unvested restricted stock units which were granted on March 8, 2018 and shall vest through March 8, 2021.
  • [F3]Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001236388

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 9:31 PM ET
Size
6.6 KB